Achieve Life Sciences, Inc.
ACHV
$2.09
-$0.05-2.34%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -33.58% | 7.39% | 33.70% | 37.59% | 29.60% |
| Total Depreciation and Amortization | 0.44% | -3.39% | -1.72% | -2.99% | -3.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.60% | 11.71% | 28.63% | 33.59% | 31.80% |
| Change in Net Operating Assets | 410.03% | 156.34% | 168.27% | -140.14% | -1,084.81% |
| Cash from Operations | -21.61% | 20.20% | 47.34% | 45.10% | 34.84% |
| Capital Expenditure | -- | 60.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -102,661.90% | -221,920.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 266.92% | 69.35% | 68.16% | 270.32% | -19.80% |
| Repurchase of Common Stock | 30.45% | 30.45% | 30.45% | -368.09% | -368.09% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | 100.00% | -- |
| Cash from Financing | 217.63% | 45.02% | 68.97% | 270.28% | -20.90% |
| Foreign Exchange rate Adjustments | 100.00% | -150.00% | -180.00% | -166.67% | -200.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 69.40% | -704.24% | -140.19% | 351.50% | 49.45% |
